Gastroparesis - Nursing Case Study
Pathophysiology
• Primary mechanism: Gastroparesis is primarily caused by impaired gastric motility due to vagus nerve dysfunction, which disrupts normal peristaltic movements essential for moving food from the stomach to the small intestine.
• Secondary mechanism: Damage to the interstitial cells of Cajal, which act as pacemakers for gastrointestinal motility, further contributes to delayed gastric emptying by impairing the coordination and strength of stomach contractions.
• Key complication: This delayed gastric emptying leads to symptoms such as nausea, vomiting, and bloating, and can cause nutritional deficiencies due to inadequate digestion and absorption of nutrients.
Patient Profile
Demographics:
45-year-old female, office manager
History:
• Key past medical history: Type 2 Diabetes Mellitus diagnosed 10 years ago, Hypothyroidism
• Current medications: Metformin, Levothyroxine, Domperidone
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent nausea and early satiety
• Key symptoms: Bloating, abdominal pain, weight loss, intermittent vomiting, fluctuating blood glucose levels
• Vital signs: Blood pressure 140/90 mmHg, heart rate 105 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F
Section 1
New Diagnostic Results:
Following the initial presentation, the healthcare team decided to perform a gastric emptying study to confirm the diagnosis of gastroparesis and assess the severity of gastric motility impairment. The results indicated a significantly delayed gastric emptying time, with only 25% of a standardized radio-labeled meal leaving the stomach after four hours. Additionally, an upper gastrointestinal endoscopy revealed mild erythematous mucosa, but no structural abnormalities that could account for the symptoms. These findings confirmed a diagnosis of moderate gastroparesis, likely exacerbated by the patient's long-standing Type 2 Diabetes Mellitus.
Laboratory tests were also conducted to evaluate the patient's nutritional status and glycemic control. The results revealed a hemoglobin A1c level of 8.5%, indicating suboptimal blood glucose management. Serum electrolytes showed mild hypokalemia and hypomagnesemia, which could contribute to the patient's nausea and fatigue. Vitamin B12 levels were on the lower end of normal, raising concerns about potential malabsorption secondary to gastroparesis. The combination of these findings suggests that the patient's gastroparesis is negatively impacting her overall metabolic control and nutritional status, necessitating a multidisciplinary approach to manage her condition effectively.
These diagnostic results provide a clearer picture of the patient's current health status and underscore the need for comprehensive management strategies. The care team must address the delayed gastric emptying, optimize glycemic control, and correct electrolyte imbalances to prevent further complications. This involves a review of her current medication regimen, potential dietary modifications, and possibly exploring prokinetic agents or alternative therapies to enhance gastric motility. The goal is to improve her symptoms and prevent the progression of gastroparesis while maintaining her overall health and quality of life.
Section 2
Despite the initial management plan targeting the gastroparesis, the patient has developed new complications that warrant further attention. Over the past week, she has experienced increased episodes of postprandial fullness and nausea, accompanied by intermittent vomiting. Upon reassessment, her vital signs reveal a heart rate of 102 beats per minute and blood pressure of 135/85 mmHg, suggesting mild tachycardia possibly related to dehydration or electrolyte imbalance. The patient's weight has decreased by 2 kg since her last visit, raising concerns about worsening nutritional status.
Laboratory tests reveal worsening hypokalemia with a serum potassium level now at 3.0 mmol/L and persistent hypomagnesemia at 1.6 mg/dL. This electrolyte disturbance may exacerbate her gastroparesis symptoms and contribute to her nausea and fatigue. Repeat serum B12 levels have dropped below the normal range, indicating significant malabsorption potentially due to poor gastric motility. Additionally, her hemoglobin A1c remains elevated at 8.4%, highlighting ongoing challenges in glycemic control, potentially related to her erratic dietary intake and absorption issues.
The care team must now consider these complications in refining her treatment plan. Addressing the electrolyte imbalances is critical, with possible intravenous supplementation for immediate correction. The patient's dietary regimen should be reassessed, with a focus on small, frequent, and low-fiber meals to mitigate the risk of gastric stasis and improve nutrient absorption. The team may also explore initiating or adjusting prokinetic therapy to enhance gastric motility. Continued monitoring and coordination with a dietitian and diabetes educator will be essential to optimize her nutritional intake and glycemic control, aiming to stabilize her condition and prevent further deterioration.
Section 3
As the care team implements the revised management plan, they decide to address the electrolyte imbalances with intravenous potassium and magnesium supplementation. The patient is admitted for close monitoring of her response to these interventions. Within 24 hours, her vital signs show slight improvement; her heart rate decreases to 95 beats per minute, and her blood pressure stabilizes at 130/80 mmHg. A repeat serum potassium level rises to 3.4 mmol/L, and magnesium improves to 1.8 mg/dL, indicating a positive response to the intravenous therapy. The patient reports a slight reduction in nausea, although she continues to experience postprandial fullness.
Given her ongoing symptoms and malabsorption issues, the team decides to adjust her prokinetic therapy, initiating low-dose erythromycin, which has been shown to enhance gastric motility. The patient is also started on a specialized diet plan developed in collaboration with a dietitian, focusing on small, frequent meals that are low in fiber and fat to minimize gastric stasis. Her glycemic control strategy is revised, incorporating frequent glucose monitoring and adjustments in her insulin regimen to accommodate her new dietary intake.
Despite these efforts, a new complication emerges. The patient begins to experience increased fatigue and mild shortness of breath. A physical examination reveals mild peripheral edema, and subsequent laboratory tests show a mild decrease in renal function, with a serum creatinine level now at 1.4 mg/dL, up from her baseline of 1.0 mg/dL. These findings raise concerns about potential fluid overload or further electrolyte imbalances, necessitating a careful reassessment of her fluid management and medication regimen. The care team considers the possibility of contributing factors such as overcorrection of electrolyte levels, medication side effects, or an underlying cardiac issue, prompting further diagnostic evaluation to determine the root cause of her new symptoms.
Section 4
The care team decides to focus on new diagnostic results to further investigate the cause of the patient's increased fatigue, mild shortness of breath, and peripheral edema. An echocardiogram is performed to assess cardiac function, revealing mild left ventricular hypertrophy, but no significant valvular abnormalities or signs of heart failure. This finding suggests that the patient's cardiac function is not the primary issue, directing attention back to her fluid and electrolyte management. Additional laboratory tests, including serum albumin and BNP levels, are ordered to further evaluate her volume status and assess for cardiac strain. The results show a serum albumin level of 3.2 g/dL, which is slightly below the normal range, and a BNP level of 100 pg/mL, indicating that heart failure is unlikely.
With these diagnostic results in hand, the team shifts focus to the possibility of fluid overload due to intravenous therapy and erythromycin's potential side effects. Given her mild renal impairment, the decision is made to adjust her fluid management strategy. The team reduces her intravenous fluid administration rate and closely monitors her electrolyte levels to prevent further imbalances. Her erythromycin dosage is also re-evaluated, and a switch to an alternative prokinetic agent is considered if her symptoms do not improve.
In response to these interventions, the patient is observed for changes in her condition over the next 48 hours. Her fluid status is closely monitored with daily weights and input-output tracking. The patient reports some improvement in her breathing and energy levels. Her peripheral edema begins to diminish as her renal function stabilizes, with serum creatinine levels returning to 1.2 mg/dL. The team remains vigilant, continuing to monitor her cardiac and renal markers, while also reinforcing the importance of dietary adherence and glycemic control to support her overall recovery and prevent further complications. This multidisciplinary approach aims to optimize her condition and address the underlying issues contributing to her gastroparesis and associated symptoms.
Section 5
As the patient continues to be monitored, a new complication arises: the patient begins to experience abdominal discomfort and increased bloating. This prompts the care team to re-evaluate her gastrointestinal management plan. An abdominal ultrasound is ordered, revealing mild gastric retention, which is consistent with her diagnosis of gastroparesis. However, the ultrasound also shows mild ascites, suggesting possible fluid accumulation in the abdominal cavity. This finding indicates that while the reduction in intravenous fluids has helped stabilize her peripheral edema, there may be localized fluid retention contributing to her symptoms.
In response to the ultrasound findings, the team conducts a paracentesis, withdrawing a small volume of ascitic fluid for analysis. The fluid is analyzed for cell count, protein concentration, and culture to rule out infection or other causes of ascites. The results show a low serum-ascites albumin gradient (SAAG), indicating that the ascites may be related to her hypoalbuminemia rather than portal hypertension. This leads to a reconsideration of her nutritional status, and the team initiates a nutritional consultation to optimize her protein intake and address her low serum albumin levels through dietary modifications.
As these new complications are addressed, the patient's condition is closely monitored, with special attention given to her abdominal symptoms and nutritional status. Her vital signs remain stable, with blood pressure at 120/75 mmHg, heart rate at 78 bpm, and oxygen saturation at 96% on room air. The care team reinforces the importance of dietary adherence and ensures that the patient's fluid intake is carefully managed to avoid exacerbating her symptoms. This integrated approach not only aims to alleviate her current discomfort but also seeks to prevent the recurrence of fluid imbalances, supporting her recovery journey and paving the way for improved management of her gastroparesis.